As of 10:30 AM on the 28th, Komipharm is trading at 12,250 KRW, up 0.82% from the previous day. This is a 21.97% decrease compared to October 6. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners are tentatively recorded as net buyers of 9,530 shares. Over the past five days, individual investors have been net sellers of 9,027 shares, while foreigners and institutions have been net sellers of 26,739 shares and net buyers of 35,841 shares, respectively.
On October 27, Komipharm became a market issue with the headline "New drug 'Kominox anticancer effect' confirmed?... Stock price rebounds."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
